IDT Supports the qPCR Community
News Jun 26, 2012
Integrated DNA Technologies (IDT) continues to provide support for life science applications with its latest successful webinar.
Over 1300 researchers registered for the live webinar entitled ‘State-of-the-art normalization of RT-qPCR data’, presented by Dr Jo Vandesompele, professor of functional genomics and applied bioinformatics at Ghent University and co-founder of real-time PCR company Biogazelle.
His expertise in the qPCR area includes numerous publications on normalization of gene expression and real-time PCR data analysis.
Available to view online, on-demand, the webinar addresses the potential pitfalls encountered when setting up a qPCR experiment. Without appropriate controls and data normalization, results can become inaccurate and misleading.
Dr Vandesompele therefore looked at the validation and selection of suitable reference genes, as well as the use of the global mean normalization method to obtain accurate data.
As a result, users can be confident in the reliability and repeatability of their amplifications. As a co-author of the MIQE guidelines, attendees benefited from Dr Vandesompele’s expertise and he was happy to answer any questions at the end of the talk.
Reinforcing the messaging of this webinar, IDT has released a free-to-download qPCR Application Guide, which provides valuable information on experimental overview, protocols, and troubleshooting.
With a dedication to developing innovative new products across qPCR, synthetic biology, RNAi, and next generation sequencing (to name a few), IDT is committed to providing useful and informative resources.
Stephen Gunstream, Vice President of Marketing at IDT commented, “Our continual investment into customer support and service, such as the development of our quarterly newsletter DECODED and the qPCR Applications Guide, has enabled us to really engage with our customers in a meaningful way - and this success has definitely been reflected in the number of registrants to this webinar. As a renowned expert within the field of qPCR, we were delighted to have Dr Vandesompele contribute not only to the recently updated qPCR Application Guide, but also in the presentation of this webinar.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018